Beam Therapeutics Stock Forecast

Stock Price Forecast

The 15 analysts that cover Beam Therapeutics stock have a consensus rating of "Buy" and an average price target of $49.13, which forecasts a 92.06% increase in the stock price over the next year. The lowest target is $21 and the highest is $80.

Price Target: $49.13 (+92.06%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$21	$49.13	$42	$80
Change	-17.90%	+92.06%	+64.19%	+212.74%

Analyst Ratings

The average analyst rating for Beam Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	5	5	5	5	6	6
Buy	4	5	5	6	7	7
Hold	2	2	2	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	12	12	14	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Luca Issi RBC Capital	RBC Capital	Hold Maintains $22 → $26	Hold	Maintains	$22 → $26	+1.64%	Feb 25, 2026
David Nierengarten Wedbush	Wedbush	Buy Maintains $57 → $65	Buy	Maintains	$57 → $65	+154.10%	Feb 25, 2026
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Strong Buy Initiates $74	Strong Buy	Initiates	$74	+189.29%	Feb 20, 2026
William Pickering Bernstein	Bernstein	Buy Maintains $37 → $41	Buy	Maintains	$37 → $41	+60.28%	Jan 21, 2026
Michael Yee UBS	UBS	Hold Initiates $28	Hold	Initiates	$28	+9.46%	Jan 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

48.28M

from 139.74M

-65.45%

from 139.74M

Revenue Next Year

65.57M

from 48.28M

35.80%

from 48.28M

EPS This Year

-4.67

from -0.81

EPS Next Year

-4.72

from -4.67

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	51.84M	60.92M	377.71M	63.52M	139.74M	48.28M	65.57M
Revenue Growth	215,916.67%	17.51%	520.01%	-83.18%	120.01%	-65.45%	35.80%
EPS	-5.77	-4.13	-1.72	-4.58	-0.81	-4.67	-4.72
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	21	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	115.5M	191.5M
Avg	48.3M	65.6M
Low	31.4M	29.8M

Revenue Growth

Revenue Growth	2026	2027
High	-17.3%	296.6%
Avg	-65.5%	35.8%
Low	-77.6%	-38.3%

EPS Forecast

EPS	2026	2027
High	-3.71	-3.40
Avg	-4.67	-4.72
Low	-5.31	-6.06

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.